Accuray Incorporated (ARAY) vs Edesa Biotech, Inc. (EDSA)
A side-by-side comparison of Accuray Incorporated and Edesa Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARAY
Accuray Incorporated
$0.31HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
EDSA
Edesa Biotech, Inc.
$3.93HealthcareDelayed quote: Oct 6, 2026, 10:02 AM EDT
Total return — ARAY vs EDSA
growth of $100 · dividends reinvested · last 10yARAY -95.0% (-25.8%/yr)EDSA -99.4% (-40.3%/yr)ARAY compounded faster over this window
Log scale — wide-divergence pair
ARAY EDSA
ARAY vs EDSA: by the numbers
- •EDSA is the larger company ($38M vs $37M market cap).
- •Both run net losses; EDSA's is the smaller (0.00% vs -12.24% net margin).
Metrics side by side
Valuation
| Metric | ARAY | EDSA |
|---|---|---|
| P/S ratio | 0.09 | N/A |
| P/B ratio | 0.88 | 94.77 |
Profitability
| Metric | ARAY | EDSA |
|---|---|---|
| Gross margin | 27.73% | 0.00% |
| Operating margin | -6.58% | 0.00% |
| Net margin | -12.24% | 0.00% |
| ROE | -117.97% | -160.05% |
| ROIC | -10.09% | -166.02% |
Growth (annualized)
| Metric | ARAY | EDSA |
|---|---|---|
| Revenue CAGR (5Y) | 0.28% | N/A |
| Total return CAGR (5Y) | -39.94% | -39.88% |
Frequently asked
- How have ARAY and EDSA total returns compared?
- Over the past 10 years, ARAY delivered -25.77% and EDSA delivered -40.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.